Donald Trump and Bernie Sanders’ agreement are difficult to find, but one agreement is that a pharmaceutical company has been driven out of Americans for a long time by robbed the price of prescription drugs. Trump said at the White House event in February, “It is not good for Americans. They can’t stand it.” In May, he announced an administrative order that the pharmaceutical company declared that if the pharmaceutical company would not adjust the US price in other countries and adjusted it, it would lower the price of the Fiat. Sanders said in a statement, “I agree with President Trump.” It is anger for American people to pay the highest price in the world for prescription drugs. “
The Trump administration was also preparing for a way for tariffs on drugs and its components, in addition to threatening to introduce price control, and many of them came from abroad. Wall Street paid attention to this threat. During the rapidly rising stock market between the Trump elections and early April, drug stocks decreased by about 20 %. It was then. Last week, the president announced plans for Trumprx, a government -run website, with Pfizer’s CEO, Albert Bourla, and Pfizer announced that some drugs will be listed at a discount of up to 85 %. The White House facts have reached a contract that the world’s fourth largest pharmaceutical company, the world’s fourth largest pharmaceutical company, has reached a contract, saying, “US pharmaceutical prices are consistent with other developed countries (most preferred countries or MFNs, prices).” Wasn’t it worse news for pharmaceuticals? Investors didn’t think so. In two days, Pfizer’s share price increased 14 %. The stocks of other pharmaceutical companies have also risen strongly in accordance with the prediction that they will attack similar transactions. At the end of the week, the S. & P. Pharmaceuticals Select Industry Industry surpassed the best in November.
The Pfizer Agreement was carefully inspected, and Trump turned out to be a paper tiger. Craig Garthwaite, head of the Kellogg Management School in North Western, said, “It’s nothing.” It will hardly affect most people. ”Boston University’s Questrom School of Business Economist and expert RENA Conti signed a similar evaluation, rather than fundamentally reconstructing drug prices and distribution, she said.
In the US pharmaceutical industry, everything is the victory of a large pharmaceutical company that preserves the current state. Journal of the American Medical AssociationThe net profit margin is 13.8 %compared to 7.7 %of S. & P. 500 companies in other sectors. A few years ago, I asked a senior executive of a prominent pharmaceutical company why I hired many lobbyists in Washington. He looked at me as if he was innocent, and the industry explained that most of the profits were generated and most of the profits in other countries such as the United Kingdom and France, the company said that the government had to negotiate the price operated by the government or negotiate the price of the government. However, in this country, health care was made and Medicare, the largest public drug buyer in the United States, could not legally negotiate with the pharmaceutical. The industry was able to claim much higher prices. It was worth paying money to the Lobbyist army to preserve this privilege.
Big Pharma spent more than $ 6.3 billion in the lobby, according to data from OpenSecets, a public interest group that tracks money in politics between 1998 and mid -year. During that period, the most important reform of drug prices was in the 2022 inflation reduction method, which allowed Medicare to set prices with pharmaceutical companies. In principle, this was a breakthrough development, but the negotiated price will not enter into force until next year and only apply to thousands of prescription drugs at first. (In the next few years, the number is going to grow.) If Trump has actually decided to confront a big constraint, he will press the quick expansion of this initiative, but he doesn’t do it. And even though he did so, he had to put the Republican Party in order to support the new legislation to collect the Republican Party, and the IRA was passed without a single GOP vote.
Instead of real reform, we now offer headline proposals to start Pfizer contracts and trumprx. In a press release on the contract, Pfizer said it will provide many primary medical medicines at half the price of the list price. This sounds likely, but industry analysts quickly pointed out that about 90 %of Americans receive prescription drugs through insurance plans. For these people, it will still be cheaper to obtain the drug in a traditional way and pay for it. Garthwaite said that purchasing drugs through TrumpRX can benefit “a small number of people” among the population without insurance coverage. But many drugs will still be very expensive. Conti calculated that pfizer can spend more than $ 150,000 a year for patients annually, despite the fact that PFIZER has received a 45 % discount on XELJANZ, a popular treatment for arthritis and other inflammatory diseases.
